Tracers / [68Ga]Ga-OncoFAP-NOTA

[68Ga]Ga-OncoFAP-NOTA

Also written as [68Ga]Ga-OncoFAP-NOTA; [Ga-68]Ga-OncoFAP-NOTA
Radionuclide
Ga-68 t½ 67.7 min
Modality
PET
Production route
Generator
Stage
Research
Syntheses indexed
0

What it is

Compound class
Small molecule chelate
Target / mechanism
FAP PMID 34957527 / DOI 10.1007/s00259-021-05653-0
Clinical application
Theranostic pair

Regulatory status

FDA
No Drugs@FDA / openFDA drug registry — no approved application found; search: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process&searchTerm=OncoFAP
EMA (centralised)
Other approvals
Brand names

Clinical use

Typical injected activity
Uptake time

Reported in the literature. Not a dosing recommendation.

Published syntheses

No synthesis has been parsed for this agent yet.

Precursor

Common precursor
NOTA-OncoFAP conjugate (from OncoFAP-COOH) PMID 36015106 / DOI 10.3390/ph15080958
Suppliers seen in the literature
Typical final purification
SPE

Need this precursor?We can point you to suppliers for [68Ga]Ga-OncoFAP-NOTA, or handle the enquiry for you.

Get in touch

Quality control Preliminary — inferred from compound class

Ph. Eur. monograph
USP monograph
AppearancepHRCP HPLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrityMolar activityMetal impuritiesGe-68 breakthrough
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); radiometal tracer -> metal impurities (rule); Ga-68, generator production assumed (no synthesis data found) -> Ge-68 breakthrough (preliminary); receptor ligand with a saturable target -> molar activity (rule)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [68Ga]Ga-OncoFAP-NOTA.

Get in touch